Showing results (361-370 of 384) with videos related to

Sort By:
Pageof 39
American Journal of Clinical Oncology|February 22, 2019
Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal CancerNabil F Saba, Seth Force, Charley Staley, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2021
Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck CancerCanhua Xiao, Andrew H Miller, Gang Peng, et al.
Nature Medicine|April 3, 2023
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trialNabil F Saba, Conor E Steuer, Asari Ekpenyong, et al.
Journal of the National Cancer Institute|September 2, 2022
Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaCristina P Rodriguez, Hyunseok Kang, Jessica L Geiger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651Robert I Haddad, Kevin Harrington, Makoto Tahara, et al.
JCO Oncology Advances|April 2, 2026
Functional impact of transoral surgery and risk-based adjuvant therapy in human papillomavirus-associated oropharyngeal cancer: swallowing outcomes from ECOG-ACRIN E3311Katherine A Hutcheson, Yael Flamand, Beatrice Manduchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck CancerRitu Chaudhary, Graydon Moorhead, Robin Park, et al.
JAMA Oncology|June 23, 2018
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical TrialRobert L Ferris, Nabil F Saba, Barbara J Gitlitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2015
A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung CancerTaofeek K Owonikoko, Suresh S Ramalingam, Daniel L Miller, et al.
Head & Neck|April 7, 2026
Colocated Multidisciplinary Clinic Is Associated With Improved Timeliness to Postoperative Adjuvant Therapy in Head and Neck Cancer PatientsGeorges E Daoud, Melissa F Riedel, Martha J Ryan, et al.
Pageof 39